Use of berberine in treating metabolism complex

A technology of metabolic syndrome and berberine, applied in the direction of metabolic diseases, drug combination, etc., can solve the lack of objective, accurate and effective evaluation in human body, stay at the level of animal experiments and in vitro research, and have no mutual connection of glucose and lipid metabolism And other issues

Inactive Publication Date: 2008-07-16
宁光
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] 2) Although glucose and lipid metabolism are inseparable, most of the previous clinical and experimental studies only emphasized the positive impact of berberine on hyperglycemia, and only a recent literature studied the clinical lipid-lowering effect of berberine, but It only mentioned its effect on blood lipids, but did not link glucose and lipid metabolism with each other
[0011] 3) The research on berberine improving insulin resistance mostly stays at the level of animal experiments and in vitro studies, so far there is a lack of objective, accurate and effective evaluation in humans
Although there have been reports on the treatment of hyperglycemia, hyperlipidemia and insulin resistance by berberine respectively, for the treatment of metabolic syndrome in human body by berberine and the comprehensive observation of the changes of each component of the latter before and after treatment, so far So far, there have been no reports at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of berberine in treating metabolism complex
  • Use of berberine in treating metabolism complex
  • Use of berberine in treating metabolism complex

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The present invention will be described in detail below in combination with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

[0027] 1. Experimental scheme of the present invention:

[0028] Using multi-center, stratified random, double-blind and placebo-controlled methods, a total of 116 patients with newly diagnosed type 2 diabetes combined with one (or more) elevated blood lipids were collected. All subjects did not receive any hypoglycemic or lipid-lowering drugs. treat. Collect relevant clinical data (including subject's age, gender...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a new application of berberine in the treatment of metabolic syndrome. Large-sample polycentric and randomized double-blind prospective experiments reveal the effect of berberine on metabolism of glucose and lipid and clarify the interrelation and common changes of the metabolism of glucose and lipid before and after berberine treatment. The berberine is used as a broad spectrum antibiotic and clinical drug with high efficiency and low toxicity for a long time and can be taken chronically without obvious side effect. Results of researches indicate that the berberine can help sufferers of type II diabetes mellitus combined with blood lipid abnormality regulate disorder of saccharometabolism and lipid metabolism, lower insulin resistance, avoid central obesity and elevation of blood pressure, thereby showing the positive effect of the berberine on the treatment of metabolic syndrome. The invention provides the new clinical application of berberine in the treatment of metabolic syndrome for human for the first time, which establishes the importance of the new clinical application of traditional Chinese medicine in the treatment of metabolic syndrome and provides a new basis as well, thereby helping to promote the traditional medicine of China.

Description

technical field [0001] The invention relates to a new application of berberine in treating metabolic syndrome. Background technique [0002] Berberine (Berberine), also known as berberine, is an isoquinoline alkaloid that exists in many plants of 4 families and 10 genera including Berberidaceae. Its molecular formula is [C20H18NO4]+ (see Figure 1), and its molecular weight is 371.8. There are many kinds of its chemical structure, including berberine hydrochloride, berberine sulfate, berberine citrate and berberine phosphate, among which the structure of berberine hydrochloride is most used clinically. [0003] Chemical structure of berberine: [0004] [0005] At present, as a broad-spectrum antibacterial drug with high efficiency and low toxicity, berberine is mainly used clinically to treat diarrhea caused by acute and chronic enteritis. The record of berberine treating diabetes was first seen in the "Famous Doctors" in the Wei and Jin Dynasties; as early as the begi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4375A61P3/00
Inventor 宁光李小英张翼飞洪洁顾卫琼张志国王卫庆霍丽朱娜顾生虹
Owner 宁光
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products